Consensus Cardlytics, Inc.

Stocks

CDLX

US14161W3034

Software

Real-time Estimate Cboe BZX 23:31:54 29/10/2026 +04			5-day change	1st Jan Change
1.655 ^USD	+3.44%		-11.76%	-85.65%

10-06	Cardlytics Inc. And Rove Team Up To Help Travelers Earn Their Next Trip Faster	CI
09-24	Similarweb Names Michael Akkerman Chief Executive	MT

Evolution of the Average Target: Cardlytics, Inc.

Evolution of the Target Price: Cardlytics, Inc.

Changes in Analyst Recommendations: Cardlytics, Inc.

0245dbd0e60b214d13b38931198286d9.35mFTfAyshbE3e1evUJJERLKRc8KY9SCMbJfqNF85rk.ksPyIZJF3meXrZw7hBYiaFasILtFIba3VfkTz7AkjsqJ9sB8oHz6eby2oA~12e8b9cae0a77a09fcc9ff1bcc6dea03

Analysts' recommendations: Cardlytics, Inc.

08-07	BofA Adjusts Price Target on Cardlytics to $4 From $8	MT
24/09/25	Cardlytics Shares Rise After Citron Research Says Company Has Multiple Opportunities to Rebuild	MT
07/08/25	Commerce media platform Cardlytics Q2 revenue falls just shy of estimates, adjusted EBITDA positive	RE
08/08/24	Lake Street Downgrades Cardlytics to Hold From Buy, Adjusts PT to $5 From $18	MT
08/08/24	Needham Downgrades Cardlytics to Hold From Buy	MT
09/05/24	Craig-Hallum Adjusts Cardlytics Price Target to $12 From $18, Maintains Buy Rating	MT
09/05/24	Needham Adjusts Price Target on Cardlytics to $12 From $17, Keeps Buy Rating	MT
09/04/24	Needham Raises Cardlytics' Price Target to $17 From $15, Maintains Buy Rating	MT
15/03/24	Craig-Hallum Upgrades Cardlytics to Buy From Hold, Adjusts Price Target to $18 From $10	MT
15/03/24	Lake Street Adjusts Cardlytics' Price Target to $18 From $13, Maintains Buy Rating	MT
29/11/23	Lake Street Starts Coverage on Cardlytics with Buy Rating, $13 Price Target	MT
02/08/23	Needham Adjusts Price Target on Cardlytics to $19 From $10, Maintains Buy Rating	MT
05/05/23	Needham Adjusts Price Target on Cardlytics to $10 From $8, Maintains Buy Rating	MT
12/04/23	Wells Fargo Adjusts Price Target on Cardlytics to $6 From $5, Keeps Underweight Rating	MT
02/03/23	JPMorgan Adjusts Cardlytics Price Target to $6 From $7, Maintains Neutral Rating	MT
02/03/23	Wells Fargo Adjusts Price Target on Cardlytics to $5 From $6, Keeps Underweight Rating	MT
02/03/23	Needham Lowers Price Target on Cardlytics to $8 From $14, Maintains Buy Rating	MT
09/01/23	Wells Fargo Adjusts Price Target on Cardlytics to $6 From $10, Maintains Underweight Rating	MT
02/11/22	Needham Adjusts Price Target on Cardlytics to $14 From $19, Maintains Buy Rating	MT
02/11/22	Wells Fargo Adjusts Cardlytics Price Target to $10 From $13, Maintains Underweight Rating	MT
08/09/22	Wells Fargo Downgrades Cardlytics to Underweight From Equalweight, Trims Price Target to $13 From $14	MT
03/08/22	Wells Fargo Trims Cardlytics Price Target to $14 From $15, Maintains Equalweight Rating	MT
03/08/22	Needham Adjusts Cardlytics' Price Target to $19 From $24, Reiterates Buy Rating	MT
14/07/22	Wells Fargo Downgrades Cardlytics to Equalweight From Overweight, Adjusts Price Target to $15 From $72	MT
13/07/22	Needham Adjusts Cardlytics' Price Target to $24 from $60, Keeps Buy Rating	MT

More recommendations

Other Software

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	CARDLYTICS, INC.					+275%
	MICROSOFT CORPORATION					+13.96%
	PALANTIR TECHNOLOGIES INC.					+6.18%
	ORACLE CORPORATION					+63.14%
	PALO ALTO NETWORKS, INC.					+1.02%
	CROWDSTRIKE HOLDINGS, INC.					-7.28%
	SAP SE					+13.13%
	SERVICENOW, INC.					+4.66%
	FORTINET, INC.					-2.66%
	DATADOG, INC.					+5.77%
	Average					+37.29%
	Weighted average by Cap.					+14.49%